
Biogen Pharmachem Industries Ltd is Rated Strong Sell
2026-05-21 10:10:22Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 21 May 2026, providing investors with the latest insights into its performance and prospects.
Read MoreBoard Meeting Outcome for Outcome Of Board Meeting Held On 5Th August 2026.
05-Aug-2026 | Source : BSEPursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Wednesday 5th August2026. at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June 2026. The board meeting commented at 03:15 PM and concluded at 03:35 PM Please take the above intimation in your records. Thanking You.
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
05-Aug-2026 | Source : BSEPFA
Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)
05-Aug-2026 | Source : BSEPFA
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
Biogen Pharmachem Industries Ltd has announced 1:6 bonus issue, ex-date: 15 May 26
No Rights history available
